Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
35094 | 53 | 32.1 | 81% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HCCR 1 | Author keyword | 6 | 100% | 8% | 4 |
2 | HUMAN CERVICAL CANCER ONCOGENE | Author keyword | 2 | 67% | 4% | 2 |
3 | HCCR | Author keyword | 1 | 50% | 4% | 2 |
4 | HCCR 2 | Author keyword | 1 | 100% | 4% | 2 |
5 | HUMAN CERVICAL CANCER ONCOGENE 1 | Author keyword | 1 | 100% | 4% | 2 |
6 | CYTOGENETIC ANALYSIS METHODS | Author keyword | 1 | 50% | 2% | 1 |
7 | CYTOGENETICS METHODS | Author keyword | 1 | 50% | 2% | 1 |
8 | NEOPLASMS DIAGNOSIS GENETICS | Author keyword | 1 | 50% | 2% | 1 |
9 | TCF BETA CATENIN | Author keyword | 1 | 50% | 2% | 1 |
10 | KEYGENE LIFE SCI | Address | 0 | 33% | 2% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HCCR 1 | 6 | 100% | 8% | 4 | Search HCCR+1 | Search HCCR+1 |
2 | HUMAN CERVICAL CANCER ONCOGENE | 2 | 67% | 4% | 2 | Search HUMAN+CERVICAL+CANCER+ONCOGENE | Search HUMAN+CERVICAL+CANCER+ONCOGENE |
3 | HCCR | 1 | 50% | 4% | 2 | Search HCCR | Search HCCR |
4 | HCCR 2 | 1 | 100% | 4% | 2 | Search HCCR+2 | Search HCCR+2 |
5 | HUMAN CERVICAL CANCER ONCOGENE 1 | 1 | 100% | 4% | 2 | Search HUMAN+CERVICAL+CANCER+ONCOGENE+1 | Search HUMAN+CERVICAL+CANCER+ONCOGENE+1 |
6 | CYTOGENETIC ANALYSIS METHODS | 1 | 50% | 2% | 1 | Search CYTOGENETIC+ANALYSIS++METHODS | Search CYTOGENETIC+ANALYSIS++METHODS |
7 | CYTOGENETICS METHODS | 1 | 50% | 2% | 1 | Search CYTOGENETICS++METHODS | Search CYTOGENETICS++METHODS |
8 | NEOPLASMS DIAGNOSIS GENETICS | 1 | 50% | 2% | 1 | Search NEOPLASMS++DIAGNOSIS++GENETICS | Search NEOPLASMS++DIAGNOSIS++GENETICS |
9 | TCF BETA CATENIN | 1 | 50% | 2% | 1 | Search TCF+BETA+CATENIN | Search TCF+BETA+CATENIN |
10 | AFP NEGATIVE | 0 | 20% | 2% | 1 | Search AFP+NEGATIVE | Search AFP+NEGATIVE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONCOGENE HCCR 2 | 20 | 100% | 17% | 9 |
2 | HCCR 1 | 3 | 100% | 6% | 3 |
3 | HCCR | 1 | 100% | 4% | 2 |
4 | GENE SPECIFIC THERAPEUTICS | 1 | 50% | 2% | 1 |
5 | APC LOCUS | 0 | 33% | 2% | 1 |
6 | SYSTEMIC PROGRESSION | 0 | 17% | 2% | 1 |
7 | HCCR 1 ONCOGENE EXPRESSION | 0 | 100% | 2% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Reflections on the implications of multistage carcinogenesis for the nature of neoplasia | 2002 | 0 | 1 | 100% |
The role of human cervical cancer oncogene in cancer progression | 2015 | 0 | 30 | 33% |
Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer | 2005 | 7 | 19 | 21% |
NEOPLASIA - A GENERAL PATHOLOGICAL REACTION | 1994 | 1 | 2 | 50% |
INVOLVEMENT OF EXTRACELLULAR-MATRIX CONSTITUENTS IN BREAST-CANCER | 1995 | 82 | 88 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KEYGENE LIFE SCI | 0 | 33% | 1.9% | 1 |
2 | BIOSYNTH NUCLE ACIDS | 0 | 14% | 1.9% | 1 |
3 | ABORATING VIRAL HEPATITIS | 0 | 13% | 1.9% | 1 |
4 | PERSONALIZIRANU MED | 0 | 100% | 1.9% | 1 |
5 | SEOCHO KUCATHOLIC MED SCI | 0 | 100% | 1.9% | 1 |
6 | ZAVOD MOL MED | 0 | 100% | 1.9% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000246275 | CDK2AP1//DOC 1//P12CDK2 AP1 |
2 | 0.0000194650 | ABT VIRALE TRANSFORMAT MECHANISMEN//AUSTRALIAN MEDICINAL PLANTS//CELLULAR AUTONOMY |
3 | 0.0000150374 | DES GAMMA CARBOXY PROTHROMBIN//GOLGI PROTEIN 73//GP73 |
4 | 0.0000133321 | RB1 GENE//RETINOBLASTOMA//RB 1 |
5 | 0.0000123039 | DRS GENE//HEPATIC LEUKEMIA FACTOR//E2A HLF |
6 | 0.0000115336 | AFFINITY MASS SPECTROMETRY//PEPTIDE CHIP ANALYSIS//PROTEOLYTIC EPITOPE EXCISION |
7 | 0.0000098781 | BMIC//APOPTOTIC INDUCTION//IN VIVO ANTIFUNGAL ACTIVITIES |
8 | 0.0000091099 | TUMORICIDAL POTENTIAL//V FES//CNRS URA 620 |
9 | 0.0000089897 | CHROMOSOME 3Q26//PAN RAS//HUMAN TELOMERASE GENE |
10 | 0.0000088949 | GLYPICAN 3//GPC3//SIMPSON GOLABI BEHMEL SYNDROME |